Targeted Therapy in Gliomas

被引:0
|
作者
Mohamed Ali Hamza
Mark Gilbert
机构
[1] The University of Texas MD Anderson Cancer Center,
来源
Current Oncology Reports | 2014年 / 16卷
关键词
Malignant gliomas; Gliomas; Radiation therapy; Chemotherapeutic agents; Oncology; Neuro-oncology; Molecular targets; Glioma patients; Central nervous system (CNS); Flioblastoma (GBM); Anaplastic gliomas; Therapeutic agents;
D O I
暂无
中图分类号
学科分类号
摘要
The survival outcome of patients with malignant gliomas is still poor, despite advances in surgical techniques, radiation therapy and the development of novel chemotherapeutic agents. The heterogeneity of molecular alterations in signaling pathways involved in the pathogenesis of these tumors contributes significantly to their resistance to treatment. Several molecular targets for therapy have been discovered over the last several years. Therapeutic agents targeting these signaling pathways may provide more effective treatments and may improve survival. This review summarizes the important molecular therapeutic targets and the outcome of published clinical trials involving targeted therapeutic agents in glioma patients.
引用
收藏
相关论文
共 50 条
  • [21] Morphological and genetic studies of gliomas to develop new approaches to targeted therapy
    Galkovsky, B.
    Mitrofanova, L.
    Lakhina, I.
    Gulyaev, D.
    Chirkin, V.
    VIRCHOWS ARCHIV, 2020, 477 : S339 - S339
  • [22] Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations
    Miklja, Zachary
    Pasternak, Amy
    Stallard, Stefanie
    Nicolaides, Theodore
    Kline-Nunnally, Cassie
    Cole, Bonnie
    Beroukhim, Rameen
    Bandopadhayay, Pratiti
    Chi, Susan
    Ramkissoon, Shakti H.
    Mullan, Brendan
    Bruzek, Amy K.
    Gauthier, Angela
    Garcia, Taylor
    Atchison, Christie
    Marini, Bernard
    Fouladi, Maryam
    Parsons, D. William
    Leary, Sarah
    Mueller, Sabine
    Ligon, Keith L.
    Koschmann, Carl
    NEURO-ONCOLOGY, 2019, 21 (08) : 968 - 980
  • [23] Targeted therapy for the treatment of gliomas with multifunctional orange emissive carbon dots
    Liu, Shuyao
    Zhong, Zhuoling
    Zhang, Chuanwei
    Zhou, Yanqu
    Fu, Chunmei
    Xu, Xiaoping
    NANOSCALE ADVANCES, 2022, 4 (03): : 894 - 903
  • [24] Understanding epilepsy in IDH-mutated gliomas: towards a targeted therapy
    Winkler, Frank
    NEURO-ONCOLOGY, 2022, 24 (09) : 1436 - 1437
  • [25] Dosimetric Impact of Source Displacement in GammaTile Surgically Targeted Radiation Therapy for Gliomas
    Ng, S.
    Yue, Y.
    Shiue, K.
    Le, Y.
    MEDICAL PHYSICS, 2022, 49 (06) : E821 - E821
  • [26] Dosimetric Impact of Source Displacement in GammaTile Surgically Targeted Radiation Therapy for Gliomas
    Ng, Sook Kien
    Yue, Yong
    Shiue, Kevin
    Shah, Mitesh V.
    Le, Yi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [27] EGFR-TARGETED THERAPY-INDUCED RESISTANCE MECHANISM IN MALIGNANT GLIOMAS
    Hwang, Inah
    Wu, Lingxiang
    Cao, Dongqing
    Hu, Baoli
    Yao, Jun
    Yu, Yao
    Wang, Qianghu
    Zheng, Hongwu
    Paik, Jihye
    NEURO-ONCOLOGY, 2018, 20 : 75 - 75
  • [28] INFANT LOW-GRADE GLIOMAS: MOLECULAR CHARACTERISTICS AND RESULTS OF TARGETED THERAPY
    Papusha, Ludmila
    Valiakhmetova, Andge
    Zaytseva, Margarita
    Druy, Alexander
    Salnikova, Ekaterina
    Vilesova, Irina
    Novichkova, Galina
    Hwang, Eugene I.
    Packer, Roger J.
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [29] Effects of targeted therapy on proliferation and migration in living slices of PDGF driven gliomas
    Assanah, Marcela
    Bruce, Jeffrey
    Canoll, Peter
    JOURNAL OF NEURO-ONCOLOGY, 2008, 87 (02) : 212 - 213
  • [30] TARGETED THERAPY FOR PEDIATRIC LOW-GRADE GLIOMAS AND PLEXIFORM NEUROFIBROMAS WITH TRAMETINIB
    Nguyen, Tiffany
    McMahon, Kathleen
    Hemenway, Molly
    Levy, Jean Mulcahy
    Foreman, Nicholas
    Dorris, Kathleen
    NEURO-ONCOLOGY, 2020, 22 : 371 - 371